↓ Skip to main content

mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo

Overview of attention for article published in Molecular Therapy, August 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
2 tweeters
patent
1 patent

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
159 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo
Published in
Molecular Therapy, August 2019
DOI 10.1016/j.ymthe.2019.05.012
Pubmed ID
Authors

Yulia Rybakova, Piotr S. Kowalski, Yuxuan Huang, John T. Gonzalez, Michael W. Heartlein, Frank DeRosa, Derfogail Delcassian, Daniel G. Anderson

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 159 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 33 21%
Researcher 20 13%
Student > Master 17 11%
Student > Bachelor 12 8%
Other 10 6%
Other 16 10%
Unknown 51 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 34 21%
Agricultural and Biological Sciences 16 10%
Pharmacology, Toxicology and Pharmaceutical Science 13 8%
Immunology and Microbiology 11 7%
Medicine and Dentistry 9 6%
Other 26 16%
Unknown 50 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2021.
All research outputs
#6,839,381
of 22,460,793 outputs
Outputs from Molecular Therapy
#2,449
of 4,429 outputs
Outputs of similar age
#107,256
of 285,095 outputs
Outputs of similar age from Molecular Therapy
#14
of 35 outputs
Altmetric has tracked 22,460,793 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 4,429 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,095 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.